Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
Primary Purpose
Progressive Keratoconus
Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Epi-keratoplasty
Collagen Cross-Linking
Femtosecond laser
Sponsored by
About this trial
This is an interventional treatment trial for Progressive Keratoconus focused on measuring Keratoconus
Eligibility Criteria
Inclusion Criteria:
- diagnosis of Keratoconus
- Age ≥ 18 years old
- Corneal thickness ≥ 400 µm
- Progressive stage 1 to 3 keratoconus (Krumeich classification)
Exclusion Criteria:
- Corneal thickness < 400µm
- Concomitant corneal disease
- History of corneal surgery
Sites / Locations
- ZhongShan Ophthalmic CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Epi-keratoplasty Group
Collagen Cross-Linking Group
Arm Description
Epi-keratoplasty Group: Reversible keratoplasty performed with only the removal of corneal epithelium of the host cornea. A donor graft is transplanted on the recipients' eye locating on the Bowman's layer.
Collagen Cross-Linking: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes
Outcomes
Primary Outcome Measures
Changes of Spherical equivalent
Secondary Outcome Measures
maximum keratometry (K-max) derived from computerized video keratography
minimum keratometry
also from computerized video keratography, the opposite description of K-max
Visual acuity
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02721628
Brief Title
Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
Official Title
Femtosecond Laser Assisted Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Unknown status
Study Start Date
September 2015 (undefined)
Primary Completion Date
December 2017 (Anticipated)
Study Completion Date
March 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sun Yat-sen University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
Detailed Description
Keratoconus is a bilateral corneal ecstatic disease which is not uncommon and always behaves progressively and results in visual impairment by inducing irregular astigmatism and corneal opacities.
Collagen Cross-Linking (CXL) is widely used in progressive keratoconus. The cornea is soaked with a riboflavin solution and then being exposed to ultraviolet-A radiation. The performance creates links between collagen fibrils in order to rigidify the corneal stroma and slow down the progression of keratoconus. However, the effectiveness is not satisfied and accompanied with risks of side effects and serious complications, such as pain for the first two post-operative days, temporary loss of visual acuity during the first three months, infection and stromal opacity due to corneal scarring.
Epi-keratoplasty is a reversible technique in which a corneal graft is transplanted on the recipients' eye with only removal of the epithelium of the receptor cornea. The procedure was assisted by femtosecond laser which allows precisely and neatly cutting. The graft strengths the whole host corneal rigidity and roughness and therefore renders the progression of keratoconus.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Progressive Keratoconus
Keywords
Keratoconus
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Epi-keratoplasty Group
Arm Type
Experimental
Arm Description
Epi-keratoplasty Group: Reversible keratoplasty performed with only the removal of corneal epithelium of the host cornea. A donor graft is transplanted on the recipients' eye locating on the Bowman's layer.
Arm Title
Collagen Cross-Linking Group
Arm Type
Active Comparator
Arm Description
Collagen Cross-Linking: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes
Intervention Type
Procedure
Intervention Name(s)
Epi-keratoplasty
Intervention Description
Femtosecond laser assisted Epi-keratoplasty
Intervention Type
Procedure
Intervention Name(s)
Collagen Cross-Linking
Other Intervention Name(s)
CCL
Intervention Description
Collagen Cross-Linking: Standard procedure, which is descriptor bellows: Corneal epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated by a UVA light for 3mW/cm2 during 30 minutes
Intervention Type
Device
Intervention Name(s)
Femtosecond laser
Intervention Description
Use in the epic-keratoplasty surgery
Primary Outcome Measure Information:
Title
Changes of Spherical equivalent
Time Frame
01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years
Secondary Outcome Measure Information:
Title
maximum keratometry (K-max) derived from computerized video keratography
Time Frame
01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years
Title
minimum keratometry
Description
also from computerized video keratography, the opposite description of K-max
Time Frame
01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years
Title
Visual acuity
Time Frame
01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years
Other Pre-specified Outcome Measures:
Title
Spherical equivalent
Time Frame
01012016~01012018: preoperatively, postoperatively 2 weeks, 1,2,3,6,12 months, 2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
diagnosis of Keratoconus
Age ≥ 18 years old
Corneal thickness ≥ 400 µm
Progressive stage 1 to 3 keratoconus (Krumeich classification)
Exclusion Criteria:
Corneal thickness < 400µm
Concomitant corneal disease
History of corneal surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Xinbo Gao, MD, PHD
Phone
+8613570942794
Email
ice.freeport@163.com
Facility Information:
Facility Name
ZhongShan Ophthalmic Center
City
GuangZhou
State/Province
Guangdong
ZIP/Postal Code
510060
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gao Xinbo, MD
Email
ice.freeport@163.com
First Name & Middle Initial & Last Name & Degree
Gao Xinbo, MD
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
undecided
Learn more about this trial
Epi-keratoplasty Versus Collagen Cross-Linking in Progressive Keratoconus
We'll reach out to this number within 24 hrs